Back to company

PHARMPROTECH HOLDING ApS: Financial statements 2024

CVR: 29174644

PHARMPROTECH HOLDING ApS (CVR 29174644) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -163,685 and a net result of DKK 5,877,922 compared with DKK 5,189,592 the year before. Equity amounted to DKK 34,598,042. The solvency ratio was 85.4%.

Gross Profit
-163,685 kr.
Profit/Loss
5,877,922 kr.
Equity
34,598,042 kr.
Total Assets
40,530,917 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--164 t.5.9 mio.34.6 mio.-
2023--17 t.5.2 mio.28.8 mio.-
2022--10 t.5.6 mio.23.6 mio.-
2021--10 t.1.3 mio.18.1 mio.-
2020--6 t.5.4 mio.16.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PHARMPROTECH HOLDING ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About PHARMPROTECH HOLDING ApS

PHARMPROTECH HOLDING ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2005. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Tony Christensen. The company is owned by Tony Christensen. In 2025, the company reported a gross profit of DKK -767,188 and a net result of DKK 3,595,179 compared with DKK 5,877,922 the year before. Equity amounted to DKK 38,132,221.